FCA Allows Defendant To Amend Pleadings To Allege Grounds Of Invalidity Not In NOA

Published date17 June 2021
Subject MatterIntellectual Property, Food, Drugs, Healthcare, Life Sciences, Patent, Food and Drugs Law, Biotechnology & Nanotechnology
Law FirmBorden Ladner Gervais LLP
AuthorMs Beverley Moore and Chantal Saunders

The Federal Court issued a decision in an action brought pursuant to the Patented Medicines (Notice of Compliance) Regulations, (the NOC Regulations), allowing a defendant (second person) to amend its pleadings to include additional allegations of invalidity not found in its Notice of Allegation (NOA).1 The plaintiff (first person) appealed the decision, and the Federal Court of Appeal (FCA) affirmed the decision.2

The FCA confirmed the conclusion that the NOC Regulations, as amended in 2017, no longer prohibit the second person from introducing new allegations of invalidity in its Statement of Defence, even if not found in its NOA to which the first person is responding. The FCA held that the Regulatory Impact Analysis Statement (RIAS), which accompanied the 2017 amendments, supports this decision.

The plaintiffs argued they made the decision to risk liability pursuant to section 8 of the NOC Regulations on the basis of the contents of the NOA and that it is unfair to permit the defendant to add new allegations, as they were denied the right to consider them when accepting the liability risk. They also argued that permitting such amendments would encourage generic companies to split their case.

The FCA held that the NOC Regulations contain checks on the generic company's incentive to withhold invalidity allegations. Section 8(6) allows the Court to consider all relevant matters in assessing the amount of compensation awarded. Further, the Court has discretion to grant or dismiss a motion to amend a pleading.

Therefore, if the Court is convinced a proposed amendment seeks to introduce invalidity allegations that the generic company was aware of when its NOA was served, the Court could refuse the amendment as not in the...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT